The FAERS Public Dashboard and its Value to the Pharmaceutical Industry
Jul 31, 2018 - 00:24:45
Radio and PodcastLive Radio & PodcastsHealth
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-figh...
About This Episode
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) is an episode from FDA Drug Information Updates by ReachMD. The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for...
Podcast
This episode belongs to FDA Drug Information Updates.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published May 4, 2018, 00:02:59 long, audio available.
Related Episodes
Continue listening to more episodes from FDA Drug Information Updates.
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Jan 7, 2018 - 00:08:29
FDA Requires New Class Warnings for All Gadolinium-Based Contrast Agents
Jan 5, 2018 - 00:02:59
The FDA's Adverse Event Reporting System (FAERS) Public Dashboard
Oct 29, 2017 - 00:09:22
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Aug 17, 2017 - 00:05:29
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Jul 28, 2017 - 00:06:00
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Jul 25, 2017 - 00:09:00
Questions About This Episode
What is FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) about?
The Food and Drug Administration (FDA) is warning that the medicine lamotrigine (Lamictal) for seizures and bipolar disorder can cause a rare but very serious reaction that excessively activates the body’s infection-fighting immune system. This can cause severe inflammation throughout the body and lead to hospitalization and death, especially if the reaction is not diagnosed and treated quickly. A link to the full communication detailing specific information for health care professionals and a list of FDA-approved GBCAs can be found at Released 4/25/2018
Where can I listen to FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)?
You can listen to FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) from?
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) is an episode from FDA Drug Information Updates by ReachMD.
How long is this episode?
This episode is 00:02:59 long.
When was this episode published?
This episode was published on May 4, 2018.
Can I save FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FDA Drug Information Updates?
Yes. This page shows related episodes from FDA Drug Information Updates when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal)?
You can listen to FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
FDA Warns of Serious Immune Reaction with Seizure/BPD Medicine Lamotrigine (Lamictal) is from FDA Drug Information Updates by ReachMD.
What are the episode details?
Published May 4, 2018 and 00:02:59 long